Credit: Shutterstock. Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types. Treatment with denosumab (Prolia ®) was associated with ...
OsStic™ Injectable Synthetic Bone Void Filler in Tibial Plateau Fracture Fixation · GlobeNewswire Inc. SHANNON, Ireland, ...
Vancouver, British Columbia — A highly controlled retrospective analysis suggests that denosumab (Prolia) leads to greater reduction in fracture risk than does zoledronic acid (Reclast) among ...
LONDON--(BUSINESS WIRE)--FOR MEDICAL BUSINESS/INDUSTRY TRADE MEDIA ONLY A real world evidence study, presented at the 13 th International Conference on Osteoporosis, Arthritis and Musculoskeletal ...
Ultragenyx and Mereo BioPharma have broken off another piece of brittle bone data, linking their drug candidate to sustained reductions in fracture rates in a midphase clinical trial. The results come ...
--Amgen today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia ® injection reduced fracture ...
Please provide your email address to receive an email when new articles are posted on . Topology-optimized splint immobilization may be preferred vs. cast immobilization after distal radius fracture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results